MAPK1 and lung carcinoma: Although CRAF is not crucial for ERK activation, its significance in tumorigenesis and cancer progression largely arises from interactions and cross-talk with other signaling pathways, culminating in non-oncogene addiction in RAS-driven lung cancers and PDAC [74, 85].